Categories Leisure & Entertainment, Technology, U.S. Markets News
Sony wins 2018 console war with success of Spider-Man and God of War
Sony is back to take home the crown in the console wars as it posted a whopping 5.6 million units in sales for the PlayStation 4 in the latest holiday season.
This brings the total 2018 sales to a staggering 91.6 million units.
With a mix of exclusives and top-notch gaming experience, Sony Interactive Entertainment America (SIE) seems to have had a very strong quarter, with the company announcing its latest sales milestone for the console.
“Thanks to the continued support from our fans during the holiday season, we are pleased to announce that PS4 has reached 91.6 million units globally. We are also happy to announce that the monthly active users of PlayStation Network continues to show strong growth, and has surpassed 90 million as of end of November 2018,” said John Kodera, President and CEO of Sony Interactive Entertainment.
According to Sony, more than 50.7 million PS4 games were sold globally during the 2018 holiday season. This brings the cumulative annual sales to 876 million PS4 games, as of December 31, 2018.
Apart from the vast array of titles from other studios, Sony also has a huge advantage when it comes to top-of-the-line exclusives. This includes The-Game-Of-The-Year winner God of War released back in April, and the Marvel’s Spider-Man launched in September 2018.
Marvel’s Spider-Man, which features an almost-free-world environment with the web-swinging superhero as its protagonist, had already crossed 9 million copies worldwide as of November 25, 2018.
Hinting at bigger things to come in 2019, CEO Kodera added, “This year, we will bring more enhanced experiences to our fans along with a highly anticipated lineup of games that are only possible on PS4.”
We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on